The DOXA-Trial is a multicentre, double blinded, randomized, placebo-controlled trial with two arms, designed to evaluate the superiority of doxapram compared with placebo in the treatment of AOP. This study protocol followed the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) guidelines [22], whereas the trial will adhere to the CONSORT (Consolidated Standards of Reporting Trials) statement [23].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile